批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2023/05/08 |
SUPPL-45(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/10/22 |
SUPPL-44(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2018/12/03 |
SUPPL-42(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2017/12/22 |
SUPPL-41(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2017/12/22 |
SUPPL-39(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2017/12/22 |
SUPPL-38(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2017/02/01 |
SUPPL-37(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2017/02/01 |
SUPPL-36(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2017/02/01 |
SUPPL-35(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2017/02/01 |
SUPPL-34(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2017/02/01 |
SUPPL-33(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/04/16 |
SUPPL-32(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/07/01 |
SUPPL-31(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/02/27 |
SUPPL-30(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/02/27 |
SUPPL-25(补充) |
Approval |
Labeling |
|
|
|
2014/02/27 |
SUPPL-22(补充) |
Approval |
Labeling |
|
|
|
2014/02/27 |
SUPPL-17(补充) |
Approval |
Labeling |
|
|
|
2013/12/26 |
SUPPL-29(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/08/06 |
SUPPL-28(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2012/11/27 |
SUPPL-26(补充) |
Approval |
Labeling |
|
|
|
2011/04/08 |
SUPPL-23(补充) |
Approval |
REMS |
|
|
|
2009/05/06 |
SUPPL-20(补充) |
Approval |
Labeling |
|
|
|
2003/06/06 |
SUPPL-16(补充) |
Approval |
Labeling |
|
|
|
1997/10/10 |
SUPPL-15(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1997/06/23 |
SUPPL-14(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1996/08/05 |
SUPPL-12(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1995/12/11 |
SUPPL-13(补充) |
Approval |
Labeling |
|
|
|
1995/04/06 |
SUPPL-11(补充) |
Approval |
Labeling |
|
|
|
1991/11/12 |
SUPPL-9(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1991/11/12 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1990/05/02 |
SUPPL-7(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1982/05/17 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1981/06/22 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
|
|
|
1979/02/26 |
ORIG-1(原始申请) |
Approval |
|
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:PHENYTOIN 剂型/给药途径:TABLET, CHEWABLE;ORAL 规格:50MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
084427 |
001 |
ANDA |
DILANTIN |
PHENYTOIN |
TABLET, CHEWABLE;ORAL |
50MG |
Prescription |
Yes |
Yes |
AB |
Approved Prior to Jan 1, 1982
|
PHARMACIA |
200691 |
001 |
ANDA |
PHENYTOIN |
PHENYTOIN |
TABLET, CHEWABLE;ORAL |
50MG |
Prescription |
No |
No |
AB |
2012/12/26
|
RISING |
200565 |
001 |
ANDA |
PHENYTOIN |
PHENYTOIN |
TABLET, CHEWABLE;ORAL |
50MG |
Prescription |
No |
No |
AB |
2014/04/17
|
TARO |
040884 |
001 |
ANDA |
PHENYTOIN |
PHENYTOIN |
TABLET, CHEWABLE;ORAL |
50MG |
Prescription |
No |
No |
AB |
2014/11/28
|
EPIC PHARMA LLC |